Target intelligence / Profile preview

Host intestinal epithelium and mucus

Molecular classification
Other
01

Overview

The host intestinal epithelium and mucus layer represent a complex physiological barrier that separates the internal milieu from the external environment of the gut lumen (Groschwitz & Hogan, 2009, PMID: 19246317). The epithelium is a single layer of specialized cells, including enterocytes, goblet cells, and Paneth cells, which are joined by tight junctions to regulate selective permeability. Overlying this is a protective mucus layer, primarily composed of the gel-forming mucin MUC2, which traps pathogens and provides a niche for the commensal microbiota (Johansson & Hansson, 2016, PMID: 27107040). This system is vital for nutrient absorption and immune tolerance, and its dysfunction is a hallmark of inflammatory bowel diseases (IBD) and various enteric infections (Okumura & Takeda, 2017, PMID: 28123927). While not a single molecular target, many therapies aim to restore its barrier function or modulate its interaction with the microbiome to treat chronic gastrointestinal disorders.

Other names
Intestinal mucosal barrierGut barrierIntestinal epitheliumMucus layerGastrointestinal barrier
02

Mechanism of action

Drugs targeting this system typically work by enhancing barrier integrity (e.g., through tight junction modulation), stimulating mucus secretion, or providing a physical protective coating to the epithelial surface to prevent irritation and pathogen attachment.

03

Biological functions

Barrier functionNutrient absorptionImmune homeostasisMucus productionPathogen defense
04

Disease associations

Inflammatory bowel diseaseCeliac diseaseIrritable bowel syndromeEnteric infectionLeaky gut syndrome
05

Safety considerations

Risk of systemic absorption of luminal toxins if barrier integrity is compromisedPotential for drug-induced mucosal injury (e.g., NSAID-induced enteropathy)Alteration of the gut microbiome composition
06

Interacting drugs

Mesalamine

4 more in the full profile.

07

Biomarkers

Fecal calprotectinZonulinMucin-2 (MUC2)Intestinal fatty acid-binding protein (I-FABP)

Beyond the preview

Go deeper on Host intestinal epithelium and mucus.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Host intestinal epithelium and mucus.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call